Exact Mass: 1494.7370854
Exact Mass Matches: 1494.7370854
Found 4 metabolites which its exact mass value is equals to given mass value 1494.7370854
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PIM4 35:3
2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)
Nociceptin (1-13), amide (TFA)
Nociceptin (1-13), amide (TFA)
C63H101F3N22O17 (1494.7666772)
Nociceptin (1-13), amide TFA is a potent ORL1 receptor (opioid receptor-like 1 receptor, OP4) agonist with a pEC50 of 7.9 for mouse vas deferens and a Ki of 0.75 nM for binding to rat forebrain membranes[1][2].
(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2z)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid
(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2z)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid
(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2e)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid
(2s,3s,4s,5s,6s)-6-[(1r,2r,4s,5r,8s,10s,13s,14r,17s,18r,21r,22r,23s)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-{[(2z)-2-methylbut-2-enoyl]oxy}-22-{[(2e)-3-phenylprop-2-enoyl]oxy}-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl]-4-{[(2s,3r,4s,5r,6r)-3-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid